TCBP - Wutah pendapatan triwulanan TC BioPharm

Logo perusahaan publik TC BioPharm (TCBP)

The quarterly revenue growth trend, where the current value is 0.00, correlates with the development of universal cell-based drugs for immediate oncology therapy. The financial foundation of TC Biopharm (TCBP) relies on a lack of debt and strict expense control. In the future, the status of innovative medicines will provide the company with the pricing power to set premium prices for its developments.

TC BioPharm (Holdings) Plc (TCBP) - Tambahing pendapatan triwulanan saka 28.04.2023 nganti 29.03.2025

Rincian metrik lan analitis perusahaan TC BioPharm (Holdings) Plc (TCBP)

Analisis dhasar perusahaan:TCBP - TC BioPharm (Holdings) PLC
Produk sing diprodhuksi TC BioPharm

To minimize the risk of capital freeze during long-term investing, it is critical to distinguish temporary seasonal spikes from sustainable trends, which allows the quarterly revenue chart to serve as a tool for capturing real sales dynamics. For TC Biopharm (TCBP), this indicator reflects the effectiveness of commercializing cell therapies, where a diversified trial portfolio smooths revenue volatility, confirming the fundamental resilience of the business model.

Pesaing wigati

argenx BVBA - Wutah pendapatan triwulanan|BNTX: Wutah pendapatan kuartal marang kuartal|ABVX: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADMA|Wutah pendapatan kuartal marang kuartal protagonist-inc.com|Wutah dodolan triwulanan Immunovant, Inc. (IMVT)|Wutah pendapatan triwulanan KNSA|GRFS: Dinamika pendapatan kuartal marang kuartal|Adaptive Biotechnologies - Wutah dodolan triwulanan|CLDX: Wutah dodolan kuartal marang kuartal|Aurinia Corp - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal BioCryst Corp|VERA: Wutah pendapatan triwulanan|dianthustx.com (DNTH) - Wutah pendapatan triwulanan|PHVS (Pharvaris NV) - Wutah pendapatan triwulanan|ABCL: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan PHAR (Pharming Corp)|nektar.com (NKTR) - Tingkat wutah pendapatan sajrone kuartal|UPB - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ZBIO (Zenas Biopharma)|IMNM: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Gossamer Bio, Inc. (GOSS)|Wutah pendapatan kuartal marang kuartal KalVista Pharmaceuticals|Septerna Inc (SEPN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan PVLA|SVRA (Savara) - Tambahing pendapatan triwulanan|Rigel Pharma - Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal AnaptysBio Corp (ANAB)|ATXS: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Wutah pendapatan kuartal marang kuartal|Aerovate Therapeutics Inc (JBIO) - Wutah pendapatan triwulanan|ACRS (Aclaris Therapeutics, Inc) - Wutah pendapatan triwulanan|Kyverna (KYTX) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan TLSA|Wutah dodolan triwulanan Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Wutah dodolan triwulanan|THTX: Wutah dodolan kuartal marang kuartal|AVTX - Wutah pendapatan kuartal marang kuartal|ELDN: Wutah pendapatan kuartal marang kuartal|Agenus Inc. (AGEN) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Climb Bio Inc|ZURA (Zura Bio Ltd) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan aTyr Pharma Inc|Wutah pendapatan triwulanan ADAG|Tingkat wutah dodolan sajrone kuartal ImageneBio|Wutah pendapatan triwulanan STTK (Shattuck Labs Inc)|Wutah pendapatan triwulanan Equillium, Inc. EQ|CNTB - Wutah pendapatan kuartal marang kuartal|Immunic Therapeutics (IMUX) - Wutah dodolan triwulanan|ATRA: Wutah pendapatan triwulanan|InflaRx GmbH (IFRX) - Wutah pendapatan triwulanan|XFOR (x4pharma.com) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Adicet Bio|Wutah pendapatan kuartal marang kuartal Celularity Inc (CELU)|Wutah dodolan triwulanan INmune Bio Corp INMB|Wutah pendapatan kuartal marang kuartal Barinthus Biotherapeutics plc BRNS|KZR - Wutah dodolan triwulanan|sabbiotherapeutics.com - Wutah pendapatan triwulanan|akaritx.com (AKTX) - Wutah dodolan triwulanan|ENLV: Wutah pendapatan triwulanan|QTTB (Q32 Bio Inc) - Wutah pendapatan kuartal marang kuartal|GOVX (geovax.com) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Edesa Biotech Corp|Wutah pendapatan triwulanan IBIO|Wutah dodolan triwulanan Carisma Tx CARM|Wutah pendapatan kuartal marang kuartal XTL Biopharmaceuticals Ltd XTLB|Wutah pendapatan triwulanan Bolt Biotherapeutics BOLT|HCW Biologics - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Wutah dodolan triwulanan|Aditxt Corp - Tambahing pendapatan triwulanan|GRI (GRI Bio Inc) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan XORTX Therapeutics Inc|Wutah pendapatan kuartal marang kuartal Vyome Therapeutics (HIND)|REVB - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Indaptus Therapeutics, Inc. INDP|Wutah pendapatan triwulanan scinai.com SCNI|CalciMedica Inc - Wutah pendapatan triwulanan|AFMD - Wutah pendapatan triwulanan|ALLK: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Wutah pendapatan triwulanan|ITOS: Tambahing pendapatan triwulanan|Wutah dodolan triwulanan OCEA (Ocean Biomedical)|THRD (Third Harmonic Bio Inc.) - Tambahing pendapatan triwulanan